Neurogenic Bowel and Management after Spinal Cord Injury: A Narrative Review

 


Executive Summary

Neurogenic bowel (NB) dysfunction is a nearly universal sequela of spinal cord injury (SCI), characterized by a spectrum of defecatory disorders and gastrointestinal (GI) motility dysfunction. It represents a significant burden on the health and quality of life of affected individuals, often leading to psychological distress, social withdrawal, and frequent hospital admissions.

The pathophysiology of NB is dictated by the level and completeness of the injury, manifesting as either hyperreflexic (supraconal) or hyporeflexic (conal/subconal) dysfunction. Effective management requires a personalized, multi-modal approach that integrates pharmacological agents, dietary modifications, mechanical interventions, and, in refractory cases, surgical options. The fundamental goal of management is to achieve regular, predictable, and complete bowel evacuation while preventing complications such as fecal incontinence, constipation, and life-threatening autonomic dysreflexia.

I. Gastrointestinal Innervation and Reflexes

The gastrointestinal tract relies on a complex interplay between the enteric nervous system (ENS) and extrinsic innervation to coordinate normal defecation.

Autonomic and Somatic Innervation

  • Enteric Nervous System (ENS): Consists of Auerbach’s myenteric plexus (motility) and Meissner’s submucosal plexus (secretion).

  • Sympathetic Nervous System (SNS):

    • Upper GI: T9–T12 preganglionic bodies via superior/inferior mesenteric ganglia.

    • Descending Colon/Rectum: T12–L3 segments via the hypogastric nerve.

    • Vascular: T7–T8 segments via the greater splanchnic nerve.

  • Parasympathetic Nervous System (PNS):

    • Upper GI to mid-transverse colon: Vagus nerve (CN-X).

    • Lower Large Bowel/Internal Anal Sphincter: Pelvic nerves from S2–S4 segments.

  • Somatic Nervous System: Provides voluntary control of the external anal sphincter and pelvic floor via the pudendal nerve (S2–S4)

Key Gut Reflexes

Defecation is assisted by several involuntary reflexes:

  1. Gastrocolic: Colonic contraction in response to stomach stretch.

  2. Colocolonic: Colonic contraction in response to colon stretch.

  3. Rectocolic: Colonic contraction in response to rectal stretch.

  4. Anorectal: Rectal vault contraction in response to anal stretch.

II. Pathophysiology of Neurogenic Bowel

SCI disrupts the coordination of the nervous system, leading to two primary patterns of dysfunction based on the location of the lesion relative to the conus medullaris.

Feature

Supraconal (Suprasacral) NB

Conal/Infraconal (Subsacral) NB

Injury Location

Above the S2–S4 segments.

At or below the S2–S4 segments (cauda equina).

Bowel Type

Hyperreflexic (Upper Motor Neuron).

Hyporeflexic/Flaccid (Lower Motor Neuron).

Colonic Tone

Hyperreflexia; high colonic pressures.

Hyporeflexia; flaccidity of colon and rectum.

Sphincter Tone

Increased tone; rectosphincter dyssynergia.

Decreased tone; weak/flaccid sphincters.

Defecation Challenge

Obstructed defecation; constipation.

Uncontrolled fecal incontinence; colonic inertia.

Reflexes

Intact (anal wink, bulbocavernosus).

Diminished or absent.

Autonomic Dysreflexia (AD)

Individuals with SCI at or above T6 are at risk for AD, a life-threatening hypertensive crisis. Bowel-related stimuli, such as distension, impaction, or hemorrhoids, are the second leading cause of AD. SNS outflow increases profoundly during AD, further reducing gut motility and complicating management.

III. Clinical Manifestations and Symptoms

Beyond defecatory dysfunction, individuals with NB frequently experience upper and lower GI symptoms:

  • Upper GI: Abdominal pain, bloating, early satiety, epigastric burning, and nausea.

  • Lower GI: Loss of voluntary control, poor awareness of stool passage, and difficulty with evacuation.

  • Secondary Complications: Small intestinal bacterial overgrowth (SIBO) due to dysmotility, hemorrhoids, diverticula, and rectal prolapse.

  • Transit Times: Total GI transit time in chronic supraconal SCI averages 3.93 days, compared to 1.76 days in non-SCI controls. In conal/infraconal injuries, times can exceed 4.91 days in the acute phase.

IV. Comprehensive Evaluation and Diagnostics

Effective management begins with a thorough clinical and diagnostic assessment.

Clinical Assessment

  • Medical History: Review of medications (e.g., opiates, anticholinergics), diet, fluid intake, and current bowel care routines.

  • Standardized Scoring: Utilization of the Bristol Stool Scale, International SCI Bowel Function Data Set (ISCIBFDS), and the Neurogenic Bowel Dysfunction Score (NBDS).

  • Physical Exam: Assessment for malnutrition/dehydration, abdominal palpation for fecal loading, and a digital rectal exam to evaluate tone, reflexes, and structural abnormalities (e.g., rectocele).

Diagnostic Testing

  • Imaging: Abdominal X-rays for impaction; CT scans for obstructions; Defecography (Fluoroscopy or MRI) for structural rectal outlet dysfunction.

  • Transit Studies: Radiopaque markers or wireless motility capsules to measure segmental colonic transit.

  • Manometry: Anorectal manometry (ARM) to identify dyssynergia or low resting pressures; Balloon Expulsion Test (BET) to evaluate pelvic floor function.

V. Management Strategies

The goal of a "Bowel Program" is to establish a personalized, consistent routine that facilitates complete evacuation within 30 to 60 minutes, ideally every 1–2 days.

Medical and Dietary Management

  • Oral Medications:

    • Stimulants: Senna, bisacodyl.

    • Osmotics: Polyethylene glycol, lactulose, magnesium citrate.

    • Novel Agents: Lubiprostone (chloride channel activator), Linaclotide (GC-C agonist), and Prucalopride (5-HT4 agonist).

    • PAMORAs: Methylnaltrexone or Alvimopan for opioid-induced constipation.

  • Dietary Fiber and Fluid: Recommendation of 25–30g of fiber and 2.5–3.0L of fluid daily. High prune intake may also resolve constipation.

  • Low FODMAP Diet: Managed by a dietician, this may reduce symptoms of gas and bloating.

Mechanical and Rehabilitative Interventions

  • Hyperreflexic NB Management: Utilization of digital rectal stimulation and rectal stimulants (suppositories like the "Magic Bullet" or docusate mini-enemas) to trigger reflex defecation.

  • Hyporeflexic NB Management: Manual disimpaction and large-volume flushing enemas (500–1000mL warm water) are most effective.

  • Transanal Irrigation (TAI): Devices like Peristeen or Navina use a rectal balloon and pump. TAI is proven to improve QOL, reduce incontinence, and decrease time spent on bowel care.

  • Biofeedback: Useful for incomplete SCI to retrain pelvic floor coordination.

Surgical Interventions

When conservative management fails or recurrent complications arise (e.g., severe pressure injuries), surgery is indicated:

  • Colostomy: A left-sided sigmoid colostomy is preferred. It streamlines bowel care, promotes independence, and generally improves quality of life.

  • Antegrade Continence Enema (ACE/LACE): The creation of a catheterizable stoma (using the appendix or descending colon) to allow for antegrade flushing of the colon.

Conclusion

Neurogenic bowel is a complex, evolving condition. Successful management relies on a close partnership between the clinician and the patient, characterized by patience, regular follow-up, and the willingness to adjust the regimen as the individual ages or their circumstances change. The overarching objective remains the maintenance of health and the promotion of a fulfilled, active life.